Cargando…
Deciphering the role of QPCTL in glioma progression and cancer immunotherapy
BACKGROUND: Glioma is the most lethal and most aggressive brain cancer, and currently there is no effective treatment. Cancer immunotherapy is an advanced therapy by manipulating immune cells to attack cancer cells and it has been studied a lot in glioma treatment. Targeting the immune checkpoint CD...
Autores principales: | Liu, Yu’e, Lu, Shaojuan, Sun, Yihong, Wang, Fei, Yu, Shibo, Chen, Xi, Wu, Lei-lei, Yang, Hui, Shi, Yufeng, Zhao, Kaijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090505/ https://www.ncbi.nlm.nih.gov/pubmed/37063864 http://dx.doi.org/10.3389/fimmu.2023.1166377 |
Ejemplares similares
-
QPCTL regulates macrophage and monocyte abundance and inflammatory signatures in the tumor microenvironment
por: Bresser, Kaspar, et al.
Publicado: (2022) -
Deciphering the potential roles of ferroptosis in regulating tumor immunity and tumor immunotherapy
por: Gu, Xu, et al.
Publicado: (2023) -
DNA Damage Response Evaluation Provides Novel Insights for Personalized Immunotherapy in Glioma
por: Chen, Mu, et al.
Publicado: (2022) -
Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022) -
Caveolin-1 promotes glioma progression and maintains its mitochondrial inhibition resistance
por: Liu, Yu’e, et al.
Publicado: (2023)